The company specializes in developing therapeutics that leverage the biology of leukocytes to combat a range of diseases, including cancer, inflammatory, autoimmune, and viral diseases. By utilizing their expertise in leukocyte biology, LeukoSite is able to discover and develop proprietary drugs that target and neutralize the disease-causing actions of leukocytes, offering new treatment options for patients. Their innovative approach has the potential to revolutionize the way we treat a variety of diseases and improve patient outcomes.